If you're a new user of Withings' fitness-tracking smartwatches or smart scales and want to sync and access your health data through third party apps like Apple Health or Google Health it's now going to cost you.

According to a discussion on Withings' support forums spotted by MacRumors, new Withings accounts created from October 13th, 2026, and onwards will require a Withings Plus subscription to use the "automatic sync to third-party apps" feature. The subscription costs $9.95 per month or $99.50 per year but Withings' devices come with a free one month trial that includes the option to sync their data to third-party apps. When the trial …

Read the full story at The Verge.

This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life. Opt in for Optimizer here.

For the past 100 days or so, my mornings have had a new rhythm. When I wake up, the first thing I have to do is feed my digital twin. It consumes my metabolic data, and its first "meal" of the day is my body composition data, sent straight from a smart scale.

Once that's logged in the app, I scoot over to the kitchen to fill an Owala with lemon water to take my medications with. That, too, gets logged in the app. On Mondays, I'll …

Read the full story at The Verge.

Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into Biohub, the nonprofit biomedical research organization founded by Mark Zuckerberg and his wife, Priscilla Chan, as reported by Reuters. The funding is part of a $1.8 billion initiative to build AI datasets that could allow researchers to "ask, predict, and answer biological questions digitally," helping find new ways to prevent and manage diseases.

Founded in 2016, Biohub aims to combat diseases through the creation of a "virtual cell" that researchers can use to carry out simulations. To support this effort, the US Department of Ene …

Read the full story at The Verge.